Literature DB >> 18568290

Is there a role for endothelin-1 in the hemodynamic changes during hemodialysis?

E M El-Shafey1, G F El-Nagar2, M F Selim2, H A El-Sorogy3, A A Sabry4.   

Abstract

BACKGROUND: The etiology of hemodialysis (HD)-induced hypotension and hypertension remains speculative. There is mounting evidence that endothelin-1 (ET-1) may play a vital role in these hemodynamic changes. We examined the possible role of intradialytic changes of ET-1 in the pathogenesis of hypotension and rebound hypertension during HD.
METHODS: The present study included 45 patients with end-stage renal disease (ESRD) on regular HD. They were divided according to their hemodynamic status during HD into three groups (group I had stable intradialytic hemodynamics, group II had dialysis-induced hypotension, and group III had rebound hypertension during HD). In addition, 15 healthy volunteers were included as a control group. Pulse and blood pressure were monitored before, during (every half hour), and after HD session. ET-1 level was measured at the beginning, middle, and end of HD. ET-1 was measured in the control group for comparison.
RESULTS: Pre-dialysis levels of ET-1 were significantly higher in dialysis patients compared to the controls (P < 0.001); however, they were comparable in the three HD groups. The post-dialysis ET-1 level was not changed significantly in group I compared with predialysis values (14.49 +/- 2.04 vs. 14.33 +/- 2.23 pg/ml; P = NS), while the ET-1 concentration decreased significantly in group II and increased in group III in comparison to predialysis values (8.56 +/- 1.44 vs. 11.75 +/- 2.51; 16.39 +/- 3.12 vs. 11.93 +/- 2.11 pg/ml, respectively; P < 0.001).
CONCLUSION: Altered ET-1 levels may be involved in the pathogenesis of rebound hypertension and hypotension during HD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18568290     DOI: 10.1007/s10157-008-0065-2

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  30 in total

Review 1.  Intradialytic complications during hemodialysis.

Authors:  Andrew Davenport
Journal:  Hemodial Int       Date:  2006-04       Impact factor: 1.812

2.  Physiological changes during hemodialysis in patients with intradialysis hypertension.

Authors:  K-J Chou; P-T Lee; C-L Chen; C-W Chiou; C-Y Hsu; H-M Chung; C-P Liu; H-C Fang
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

Review 3.  Hypertension in chronic renal failure and ESRD: prevalence, pathophysiology, and outcomes.

Authors:  L U Mailloux
Journal:  Semin Nephrol       Date:  2001-03       Impact factor: 5.299

4.  'Paradoxical' rise in blood pressure during ultrafiltration in dialysis patients.

Authors:  M Cirit; F Akçiçek; E Terzioğlu; C Soydaş; E Ok; C F Ozbaşli; A Başçi; E J Mees
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

5.  Hemodynamic effects of endothelin-1 and big endothelin-1 in chronic hemodialysis patients.

Authors:  A Ottosson-Seeberger; G Ahlborg; A Hemsén; J M Lundberg; A Alvestrand
Journal:  J Am Soc Nephrol       Date:  1999-05       Impact factor: 10.121

6.  Endothelin in renal failure.

Authors:  A N Warrens; M J Cassidy; K Takahashi; M A Ghatei; S R Bloom
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

Review 7.  Endothelin-1-induced signaling pathways in vascular smooth muscle cells.

Authors:  Ali Bouallegue; Grace Bou Daou; Ashok K Srivastava
Journal:  Curr Vasc Pharmacol       Date:  2007-01       Impact factor: 2.719

8.  Plasma endothelin levels in hypertension and chronic renal failure.

Authors:  M Shichiri; Y Hirata; K Ando; T Emori; K Ohta; S Kimoto; M Ogura; A Inoue; F Marumo
Journal:  Hypertension       Date:  1990-05       Impact factor: 10.190

Review 9.  Endothelin-1 in chronic renal failure and hypertension.

Authors:  Richard Larivière; Marcel Lebel
Journal:  Can J Physiol Pharmacol       Date:  2003-06       Impact factor: 2.273

10.  Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis.

Authors:  T Akizawa; E Kinugasa; S Koshikawa
Journal:  ASAIO Trans       Date:  1991 Jul-Sep
View more
  23 in total

Review 1.  The growing problem of intradialytic hypertension.

Authors:  Francesco Locatelli; Andrea Cavalli; Benedetta Tucci
Journal:  Nat Rev Nephrol       Date:  2009-11-24       Impact factor: 28.314

2.  Intradialytic hypertension and the association with interdialytic ambulatory blood pressure.

Authors:  Peter N Van Buren; Catherine Kim; Robert Toto; Jula K Inrig
Journal:  Clin J Am Soc Nephrol       Date:  2011-07       Impact factor: 8.237

Review 3.  Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension.

Authors:  Peter Noel Van Buren; Jula K Inrig
Journal:  Semin Dial       Date:  2017-06-30       Impact factor: 3.455

4.  Associations of endothelial dysfunction and arterial stiffness with intradialytic hypotension and hypertension.

Authors:  Ruth Dubin; Christopher Owens; Warren Gasper; Peter Ganz; Kirsten Johansen
Journal:  Hemodial Int       Date:  2011-06-09       Impact factor: 1.812

Review 5.  Interdialytic ambulatory blood pressure in patients with intradialytic hypertension.

Authors:  Peter N Van Buren; Robert Toto; Jula K Inrig
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

Review 6.  Intradialytic hypotension.

Authors:  Wesley Hayes; Daljit K Hothi
Journal:  Pediatr Nephrol       Date:  2010-10-22       Impact factor: 3.714

Review 7.  Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis.

Authors:  Jula K Inrig
Journal:  Am J Kidney Dis       Date:  2009-10-22       Impact factor: 8.860

8.  Hemodialysis patients with intradialytic rise in blood pressure display higher baseline aortic stiffness and negligible drop in augmentation index with dialysis.

Authors:  Panagiotis I Georgianos; Fani Mpoutsiouki; Erasmia Sabani; Dimitrios N Stamatiadis; Vassilios Liakopoulos; Elias V Balaskas; Pantelis E Zebekakis; Pantelis A Sarafidis
Journal:  Int Urol Nephrol       Date:  2016-01-14       Impact factor: 2.370

Review 9.  Mechanisms and Treatment of Intradialytic Hypertension.

Authors:  Peter Noel Van Buren; Jula K Inrig
Journal:  Blood Purif       Date:  2016-01-15       Impact factor: 2.614

Review 10.  Intradialytic Blood Pressure Abnormalities: The Highs, The Lows and All That Lies Between.

Authors:  Magdalene M Assimon; Jennifer E Flythe
Journal:  Am J Nephrol       Date:  2015-11-20       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.